Loading...
•
Mar 31, 2024
Stryker Q1 2024 Earnings Report
Stryker reported a strong first quarter with significant growth in net sales and earnings.
Key Takeaways
Stryker's Q1 2024 results showed a 9.7% increase in reported net sales to $5.2 billion and a 10.0% increase in organic net sales. The company's reported EPS increased by 33.1% to $2.05, and adjusted EPS increased by 16.8% to $2.50. Management is confident in the company's ability to grow sales and drive strong adjusted earnings growth in 2024.
Reported net sales increased by 9.7% to $5.2 billion.
Organic net sales increased by 10.0%.
Reported EPS increased by 33.1% to $2.05.
Adjusted EPS increased by 16.8% to $2.50.
Revenue by Segment
Forward Guidance
Stryker now expects full year 2024 organic net sales growth to be in the range of 8.5% to 9.5% and adjusted net earnings per diluted share to be in the range of $11.85 to $12.05.
Positive Outlook
- Strong procedural volumes
- Healthy demand for capital products
- Commitment to expanding operating margins
Challenges Ahead
- Foreign exchange rates will moderately unfavorably impact net sales for the full year.
- Adjusted net earnings per diluted share will be negatively impacted at the higher end of our previously guided range of $0.05 to $0.10 for the full year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...